IQV Falls -15% In 5-day Spree On Bleak 2026 Guidance & Analyst Cuts
IQVIA (IQV) – a provider of cloud-based analytics and clinical research services – hit a 5-day losing streak, with cumulative losses over this period amounting to -15%. The company’s market cap has crashed by about $4.8 Bil over the last 5 days and currently stands at $28 Bil.
The stock has YTD (year-to-date) return of 27.0% compared to 0% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity or a trap.
What Triggered The Slide?
[1] Disappointing 2026 Profit Guidance
- How Low Can AMT Really Go In A Market Crash?
- Stress Testing CEG: Historical Drawdowns and Macro Risks
- Stress Testing BSX: Historical Drawdowns and Macro Risks
- Stress Testing GLW: Historical Drawdowns and Macro Risks
- Stress Testing ACN: Historical Drawdowns and Macro Risks
- The Bear Case: How BKNG Behaves During Market Shocks
- FY2026 EPS guidance of $12.55-$12.85 missed analyst consensus of $12.95
- Stock dropped 8.5% in morning trading following the announcement
- Impact: Sharp sell-off post-earnings, Negative investor sentiment
[2] Wave of Analyst Price Target Cuts
- TD Cowen lowered price target to $174 from $245, citing AI risks
- Jefferies, JPMorgan, and Evercore ISI also reduced price targets
- Impact: Sustained downward pressure on stock, Heightened concerns over future growth
Opportunity or Trap?
Below is our take on valuation.
There are a few things to fear in IQV stock given its overall Weak operating performance and financial condition. This is aligned with the stock’s Low valuation because of which we think it is Fairly Priced (For details, see Buy or Sell IQV).
But here is the real interesting point.
You are reading about this -15% move after it happened. The market has already priced in the news. To avoid the next loser before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has a risk model designed to reduce exposure to losers.
Returns vs S&P 500
The following table summarizes the return for IQV stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | IQV | S&P 500 |
|---|---|---|
| 1D | -1.5% | 0.1% |
| 5D (Current Streak) | -14.7% | -1.7% |
| 1M (21D) | -31.8% | -1.5% |
| 3M (63D) | -26.4% | 1.6% |
| YTD 2026 | -27.0% | -0.0% |
| 2025 | 14.7% | 16.4% |
| 2024 | -15.1% | 23.3% |
| 2023 | 12.9% | 24.2% |
Take a look at what history tells you about whether past dips like this have been buying opportunities or traps: IQV Dip Buyer Analysis.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 44 S&P constituents with 3 days or more of consecutive gains and 40 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 18 | 25 |
| 4D | 6 | 4 |
| 5D | 6 | 7 |
| 6D | 5 | 3 |
| 7D or more | 9 | 1 |
| Total >=3 D | 44 | 40 |
Key Financials for IQVIA (IQV)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $15.0 Bil | $15.4 Bil |
| Operating Income | $2.1 Bil | $2.3 Bil |
| Net Income | $1.4 Bil | $1.4 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $4.0 Bil | $4.1 Bil |
| Operating Income | $538.0 Mil | $573.0 Mil |
| Net Income | $266.0 Mil | $331.0 Mil |
The losing streak IQV stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.